Dennis Hom
Geen lopende functies
Vermogen: - $ op 30-04-2024
Profiel
Dennis Hom worked as an Executive Director of Corporate Development at Amgen, Inc. from 2011 to 2012.
He then worked as a Vice President of Finance and Corporate Development at Achaogen, Inc. from 2013 to 2014.
Currently, he is the CFO and Head of Corporate Development at Sagimet Biosciences, Inc. starting from 2017 and continuing until 2023.
Hom received his undergraduate degree from the Massachusetts Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-07-2023 | 0 ( -.--% ) | - $ | 30-04-2024 |
Eerdere bekende functies van Dennis Hom
| Bedrijven | Functie | Einde |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Financieel Directeur/CFO | 01-08-2023 |
| ACHAOGEN | Financieel Directeur/CFO | 31-03-2014 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2012 |
Opleiding van Dennis Hom
| Massachusetts Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
